Maulik Nanavaty - 25 May 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role: Director
Signature: /s/ Josh Seidenfeld, Attorney-in-Fact for Maulik Nanavaty
Issuer symbol: RANI
Transactions as of: 25 May 2023
Transactions value $: $0
Form type: 4
Filing time: 30 May 2023, 20:09:06 UTC
Previous filing: 27 May 2022
Next filing: 20 Nov 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RANI	Stock Option (Right to Buy)	Award	$0	+101K		$0.00	101K	25 May 2023	Class A Common Stock	101K	$4.11	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).

Content

The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).